Psoriatic Arthritis Therapeutics Market by Drug Class (Interleukin Inhibitors, TNF Inhibitors, PDE4 Inhibitors, and Others), by Disease Type (Asymmetric Psoriatic Arthritis, Symmetric Psoriatic Arthritis, Distal Interphalangeal Predominant (DIP) Psoriatic Arthritis, Spondylitis, and Arthritis Mutilans), and by Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies)-Global Industry Analytics, COVID-19 Business Impact, and Trends, 2020–2029

                                          
Abstract
                    
The report covers a forecast and an analysis of the psoriatic arthritis therapeutics market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes the drivers and restraints of the psoriatic arthritis therapeutics market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the psoriatic arthritis therapeutics market on a global level.

In order to give the users of this report a comprehensive view of the psoriatic arthritis therapeutics market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.


The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.

The study provides a decisive view of the psoriatic arthritis therapeutics market by segmenting it based on drug class, disease type, distribution channel, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Some major players of the global psoriatic arthritis therapeutics market include AbbVie, Amgen, Celgene Corporation, Janssen Biotech, UCB, Pfizer, Biogen, Novartis AG, Eli Lilly and Company, and Bristol-Myers Squibb.

This report segments the global psoriatic arthritis therapeutics market into:

Global Psoriatic Arthritis Therapeutics Market: Drug Class Analysis

	Interleukin Inhibitors
	TNF Inhibitors
	PDE4 Inhibitors
	Others

Global Psoriatic Arthritis Therapeutics Market: Disease Type Analysis

	Asymmetric Psoriatic Arthritis
	Symmetric Psoriatic Arthritis
	Distal Interphalangeal Predominant (DIP) Psoriatic Arthritis
	Spondylitis
	Arthritis Mutilans

Global Psoriatic Arthritis Therapeutics Market: Distribution Channel Analysis

	Hospital Pharmacies
	Online Pharmacies
	Retail Pharmacies

Global Psoriatic Arthritis Therapeutics Market: Regional Analysis

	North America
	
		The U.S.
	
	
	Europe
	
		UK
		France
		Germany
	
	
	Asia Pacific
	
		China
		Japan
		India
	
	
	Latin America
	
		Brazil
	
	
	Middle East and Africa